July 22, 2011 – Varian Medical Systems announced its Aria software for electronic medical records (EMR) and clinical practice management in radiation oncology has been certified for clinics that can now use it to qualify for federal funding under the United States HITECH Act.

Aria for radiation oncology (Version 11) received complete EMR certification for ambulatory environments from the Drummond Group. Tested under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, the Aria radiation oncology system was certified as 2011/2012 compliant in accordance with the criteria adopted by the U.S. Secretary of Health and Human Services. Varian's Aria for medical oncology practice management was similarly certified in May.

Aria provides oncology clinics with software for managing the full spectrum of clinical, administrative, and financial activities. It incorporates a comprehensive oncology-specific EMR that enables clinicians to design a personalized care path for each patient, from initial diagnosis through follow-up. Aria has been rated among the top three oncology IT solutions every year since 2008 by KLAS, an independent research firm that reports on the performance of healthcare vendors.

Drummond Group's ONC-ATCB 2011/2012 certification program tests EMRs to determine if they meet the eligibility requirements to be considered a certified EMR under the HITECH Act. In turn, healthcare providers using the EMR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology – a key component of the federal government's push to improve clinical care delivery through the adoption and meaningful use of EMRs by U.S. healthcare providers.

To help Aria users qualify for incentive payments under the HITECH Act, Varian has also launched a number of customer service programs, including clinical consulting services and regularly scheduled symposia and online webinars that cover how to use Aria to demonstrate meaningful use of an EMR.

This complete EMR is 2011/2012 compliant and has been certified by Drummond Group, an ONC-ATCB approved to certify any complete or modular EMR, both ambulatory and inpatient, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.

For more information: www.varian.comwww.drummondgroup.com


Related Content

News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
Feature | Radiology Business

ITN conducts a bi-monthly survey to its readers on a variety of topics, which is used to create the Last Read, a unique ...

Time July 08, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now